ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

PPBT Purple Biotech Ltd

0.5011
-0.0089 (-1.75%)
시간외 거래
최종 업데이트: 05:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Purple Biotech Ltd PPBT 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0089 -1.75% 0.5011 05:00:00
개장가 저가 고가 종가 전일 종가
0.54 0.50 0.54 0.5011 0.51
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer..
28/03/202420:00GLOBEPurple Biotech to Present New Data On its Oncology Drug..
14/03/202420:30GLOBEPurple Biotech Reports Preclinical Proof of Concept for its..
07/03/202406:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/03/202406:00EDGAR2Form 20-F - Annual and transition report of foreign private..
05/03/202421:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/03/202421:55GLOBEPurple Biotech Reports Fourth Quarter and Full-Year 2023..
27/02/202421:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/02/202421:00GLOBEPurple Biotech Presents Data of its Phase 1 Head & Neck..
13/02/202421:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/02/202421:00GLOBEPurple Biotech Convenes a Head & Neck Cancer Scientific..
01/02/202421:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/02/202421:30GLOBEPurple Biotech Reaches Recommended Phase 2 Dose for NT219
27/01/202406:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202322:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202322:05GLOBEPurple Biotech Appoints Dr. Yael Margolin to its Board of..
14/12/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202320:50GLOBEPurple Biotech Completes Patient Enrollment in Phase 2..
21/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202320:50GLOBEPurple Biotech Reports Third Quarter 2023 Financial Results
15/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
15/11/202306:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202306:11EDGAR2Form F-1/A - Registration statement for certain foreign..
02/11/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202320:00GLOBEPurple Biotech Fortifies NT219 Patent Protection
31/10/202305:30EDGAR2Form F-1 - Registration statement for certain foreign..
20/10/202305:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202305:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/10/202304:55GLOBEPurple Biotech Announces Closing of $5 Million Registered..
19/10/202323:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202323:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/10/202321:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202321:00GLOBEPurple Biotech Announces $5 Million Registered Direct..
17/10/202320:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/10/202320:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/10/202321:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/10/202320:50GLOBEPurple Biotech Reports Potential Biomarker Data Support..
03/10/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202320:50GLOBEPurple Biotech Reports Positive Interim and Preliminary..
21/09/202321:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/09/202321:00GLOBEPurple Biotech to Present New CM24 Pancreatic Cancer..
13/09/202321:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/08/202322:29GLOBEPurple Biotech Reports Second Quarter 2023 Financial Results
22/08/202321:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202321:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202321:15GLOBEPurple Biotech Reports Positive Results of CM24 Dose..